Literature DB >> 20636450

Prevalence and European comparison of dementia in a ≥75-year-old composite population in Spain.

J Virués-Ortega1, J de Pedro-Cuesta, S Vega, M Seijo-Martínez, P Saz, F Rodríguez, A Rodríguez-Laso, R Reñé, S P de Las Heras, R Mateos, P Martínez-Martín, I Mahillo-Fernández, S López-Pousa, A Lobo, J L Reglà, J Gascón, F J García, M Fernández-Martínez, R Boix, F Bermejo-Pareja, A Bergareche, F Sánchez-Sánchez, A de Arce, J L del Barrio.   

Abstract

OBJECTIVES: To estimate dementia prevalence in Spain.
MATERIALS AND METHODS: Nine probabilistic and geographically defined samples participated. A screening design based on the MMSE was implemented. Positively screened individuals underwent clinical evaluation. The total number of cases in Spain was estimated. Prevalence was confronted to that of other European countries.
RESULTS: Five hundred and forty-six persons aged ≥75 participated, 49 had dementia (35 with Alzheimer's disease [AD], 10 with vascular dementia [VD], 4 other; 25 first diagnosed in the study). Age- and sex-adjusted prevalence and estimated nationwide cases were 7.5% (95% CI 5.4-9.7), 5.6 (95% CI 3.7-7.5) and 1.4 (95% CI 0.5-2.3), and 290,000 (95% CI 208,000-372,000), 214,000 (95% CI 141,000-288,000) and 54,000 (95% CI 20,000-88,000) for dementia, AD and VD, respectively.
CONCLUSIONS: Dementia prevalence in Spain is comparable to other European populations, while a high number of undiagnosed cases live in the community. The potential impact of Mediterranean diet, hypertension control and decreasing vascular risk factors is discussed.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 20636450     DOI: 10.1111/j.1600-0404.2010.01398.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  10 in total

Review 1.  Drug use in patients with dementia: a register-based study in the health region of Girona (Catalonia/Spain).

Authors:  Pilar Avila-Castells; Josep Garre-Olmo; Laia Calvó-Perxas; Oriol Turró-Garriga; Elisabet Alsina; Olga Carmona; Héctor Perkal; Anna Maria Roig; Josep Ma Cuy; Manuela Lozano; Albert Molins; Natàlia Vallmajó; Secundino López-Pousa
Journal:  Eur J Clin Pharmacol       Date:  2012-11-23       Impact factor: 2.953

2.  Design, methods and demographic findings of the DEMINVALL survey: a population-based study of Dementia in Valladolid, Northwestern Spain.

Authors:  Miguel Angel Tola-Arribas; María José Garea; María Isabel Yugueros; Fernando Ortega-Valín; Ana Cerón; Beatriz Fernández-Malvido; Marta González-Touya; Antonio San José; Ana Botrán; Vanessa Iglesias; Bárbara Díaz-Gómez
Journal:  BMC Neurol       Date:  2012-08-30       Impact factor: 2.474

3.  Prevalence of disability in a composite ≥75 year-old population in Spain: a screening survey based on the International Classification of Functioning.

Authors:  Javier Virués-Ortega; Jesús de Pedro-Cuesta; Manuel Seijo-Martínez; Pedro Saz; Fernando Sánchez-Sánchez; Fermina Rojo-Pérez; Fernanda Rodríguez; Raimundo Mateos; Pablo Martínez-Martín; Ignacio Mahillo; Jordi Gascon-Bayarri; Josep Garre-Olmo; Francisco Jose García; Gloria Fernández-Mayoralas; Felix Bermejo-Pareja; Alberto Bergareche; Javier Almazan-Isla; Jose Luis del Barrio
Journal:  BMC Public Health       Date:  2011-03-23       Impact factor: 3.295

4.  Prevalence of cognitive impairment in individuals aged over 65 in an urban area: DERIVA study.

Authors:  Emiliano Rodríguez-Sánchez; Sara Mora-Simón; María C Patino-Alonso; Ricardo García-García; Alfonso Escribano-Hernández; Luis García-Ortiz; Ma Victoria Perea-Bartolomé; Manuel A Gómez-Marcos
Journal:  BMC Neurol       Date:  2011-11-17       Impact factor: 2.474

5.  Diagnosis of Dementia in the Specialist Setting: A Comparison Between the Swedish Dementia Registry (SveDem) and the Registry of Dementias of Girona (ReDeGi).

Authors:  Josep Garre-Olmo; Sara Garcia-Ptacek; Laia Calvó-Perxas; Oriol Turró-Garriga; Secundino López-Pousa; Maria Eriksdotter
Journal:  J Alzheimers Dis       Date:  2016-07-01       Impact factor: 4.472

6.  A protective personal factor against disability and dependence in the elderly: an ordinal regression analysis with nine geographically-defined samples from Spain.

Authors:  Javier Virues-Ortega; Saturio Vega; Manuel Seijo-Martinez; Pedro Saz; Fernanda Rodriguez; Angel Rodriguez-Laso; Susana Perez de Las Heras; Raimundo Mateos; Pablo Martinez-Martin; Ignacio Mahillo-Fernandez; Josep Garre-Olmo; Jordi Gascon; Francisco Jose Garcia-Garcia; Manuel Fernandez-Martinez; Felix Bermejo-Pareja; Alberto Bergareche; Julian Benito-Leon; Jesus de Pedro-Cuesta
Journal:  BMC Geriatr       Date:  2017-01-31       Impact factor: 3.921

7.  A Systematic Review and Meta-Analysis on the Prevalence of Dementia in Europe: Estimates from the Highest-Quality Studies Adopting the DSM IV Diagnostic Criteria.

Authors:  Ilaria Bacigalupo; Flavia Mayer; Eleonora Lacorte; Alessandra Di Pucchio; Fabrizio Marzolini; Marco Canevelli; Teresa Di Fiandra; Nicola Vanacore
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  Epidemiology of dementia: prevalence and incidence estimates using validated electronic health records from primary care.

Authors:  Anna Ponjoan; Josep Garre-Olmo; Jordi Blanch; Ester Fages; Lia Alves-Cabratosa; Ruth Martí-Lluch; Marc Comas-Cufí; Dídac Parramon; María Garcia-Gil; Rafel Ramos
Journal:  Clin Epidemiol       Date:  2019-03-04       Impact factor: 4.790

9.  Is it time to use real-world data from primary care in Alzheimer's disease?

Authors:  Anna Ponjoan; Josep Garre-Olmo; Jordi Blanch; Ester Fages; Lia Alves-Cabratosa; Ruth Martí-Lluch; Marc Comas-Cufí; Dídac Parramon; María Garcia-Gil; Rafel Ramos
Journal:  Alzheimers Res Ther       Date:  2020-05-18       Impact factor: 6.982

10.  [Quality of registration of dementia diagnosis in primary care: The situation in Spain in 2002-2011].

Authors:  María del Canto de Hoyos-Alonso; Julio Bonis; Verónica Bryant; María Victoria Castell Alcalá; Ángel Otero Puime
Journal:  Aten Primaria       Date:  2015-05-27       Impact factor: 1.137

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.